Brief: Bellicum Pharmaceuticals Says Co Entered Into An Open Market Sale Agreement With Jefferies LLC
05/10/2018 21:53
Oct 5 (Reuters) - Bellicum Pharmaceuticals Inc BLCM.O :
* BELLICUM PHARMACEUTICALS - ON OCTOBER 5, CO ENTERED INTO
AN OPEN
MARKET SALE AGREEMENT WITH JEFFERIES LLC - SEC FILING
* BELLICUM PHARMACEUTICALS INC - AS PER AGREEMENT, CO MAY
SELL
THROUGH JEFFERIES, COMMON STOCK HAVING OFFERING PRICE OF UP TO
$60.0 MILLION
Source text: (https://bit.ly/2QxtRP0)
Further company coverage: BLCM.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Bellicum Pharmaceuticals
See all newsBrief: Bellicum Pharmaceuticals- In Connection With Dissolution And Plan Of Dissolution, On February 23, Richard A. Fair Resigned As President And Co's CEO
Brief: Bellicum Pharmaceuticals Says Board Approved Liquidation And Dissolution Of Co In Connection With Approval Of Asset Purchase Agreement
Brief: Bellicum Pharmaceuticals Initiated A 12 Stock Split On Dec 8, 2022
Brief: Bellicum Reports Third Quarter 2022 Financial Results And Provides Operational Update
Bellicum Pharmaceuticals Inc expected to post a loss of 64 cents a share - Earnings Preview